Newsbenzinga
Bio‑Techne And Refeyn Launch An Integrated Workflow To Characterize Charge And Size Variants In Bispecific Antibodies And Biosimilars
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…